Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. MRK
MRK logo

MRK

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

MRK News

Calderasib Receives Breakthrough Therapy Designation

22h agoNewsfilter

Dell Technologies Poised to Dominate Computer Market

10h agoCNBC

Dell Technologies Earnings Ignite AI Enthusiasm

11h agoNewsfilter

FDA Proposes Reducing Animal Studies for Cancer Drugs

19h agoseekingalpha

Analysis of High-Yield Dividend ETF Investments

22h agoFool

Vanguard High Dividend ETF Underperforms S&P 500

22h agoNASDAQ.COM

Multiple Companies Declare Quarterly Dividends

2d agoNASDAQ.COM

Merck Declares Q3 2026 Dividend of $0.85

3d agoNewsfilter

Adcendo Partners with MSD for Phase Ib Trial of ADCE-T02 with KEYTRUDA

3d agoYahoo Finance

Absci Corp: The Future Potential of Drug Discovery

4d agoFool

Absci Leverages AI to Design Protein Drugs

4d agoNASDAQ.COM

Three Great Dividend Stocks to Buy and Hold for the Next Decade

4d agoFool

US Stocks Close Higher as Market Sentiment Improves

May 22 2026NASDAQ.COM

Healthcare Stocks Surge Due to Innovation and Policy Changes

May 22 2026NASDAQ.COM

Healthcare Sector Sees Best Week in Six Months

May 22 2026Fool

U.S. Stocks Close Higher, S&P 500 Approaches 7,500

May 22 2026CNBC